GB:CRTX Stock Latest News
Company AnnouncementsCRISM Therapeutics Issues New Equity Ahead of ChemoSeed Trial Progress2w ago
Company AnnouncementsCRISM Therapeutics Sets AGM Date as Phase 2 Glioblastoma Trial Recruitment Begins1M ago
Company AnnouncementsCRISM Therapeutics advances Phase 2 glioblastoma trial and strengthens funding for ChemoSeed platform1M ago
Company AnnouncementsCRISM Therapeutics names seasoned healthcare dealmaker as chair amid Phase 2 trial push1M ago
Company AnnouncementsCRISM Therapeutics Starts Phase II ChemoSeed Trial in Glioblastoma2M ago
Company AnnouncementsCRISM Therapeutics Clears Key Step to Begin Phase II Glioblastoma Trial2M agoCompany AnnouncementsCRISM Therapeutics Reveals Concentrated Shareholder Base After Register Analysis3M ago
- Company AnnouncementsCRISM secures key approvals and funding as ChemoSeed platform advances toward Phase 24M ago
Company AnnouncementsCRISM advances Phase 2 ChemoSeed trial for glioblastoma4M ago- Company AnnouncementsCRISM Therapeutics Wins Shareholder Backing and Expands Capital Base After Funding Round4M ago
Company AnnouncementsCRISM wins major UK grant to advance Phase 2 glioblastoma trial5M ago
Company AnnouncementsCRISM wins Invest NI grant to advance prostate cancer ChemoSeed programme5M agoCompany AnnouncementsCRISM Therapeutics Upsizes Oversubscribed Retail Offer to Fund Cancer Drug Delivery Trials5M ago
Company AnnouncementsCRISM Therapeutics launches retail offer to fund oncology pipeline5M ago
Company AnnouncementsCRISM Therapeutics Raises £2.5m to Advance ChemoSeed Cancer Trials5M ago- Company AnnouncementsCRISM Therapeutics Reports Strong Preclinical Prostate Cancer Data for Docetaxel-ChemoSeed6M ago
Company AnnouncementsCRISM Therapeutics reshapes board leadership as it advances toward phase 2 trial7M ago
Company AnnouncementsCRISM Therapeutics Pushes Phase 2 Glioblastoma Trial Start to H1 2026 After First ChemoSeed Batch Produced7M ago